Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $2.9 in the prior trading day, Aspen Aerogels Inc (NYSE: ASPN) closed at $2.96, up 2.07%. In other words, the price has increased by $2.07 from its previous closing price. On the day, 2.7 million shares were traded. ASPN stock price reached its highest trading level at $2.98 during the session, while it also had its lowest trading level at $2.8601.
Ratios:
Our goal is to gain a better understanding of ASPN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.60 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 90.94. For the most recent quarter (mrq), Quick Ratio is recorded 3.33 and its Current Ratio is at 3.94. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.38.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 13 ’25 when Young Donald R sold 56,845 shares for $3.23 per share. The transaction valued at 183,609 led to the insider holds 494,011 shares of the business.
DONALD YOUNG bought 56,845 shares of ASPN for $194,978 on Nov 13 ’25. On Aug 12 ’25, another insider, Daniel Santhosh P, who serves as the Chief Accounting Officer of the company, sold 4,410 shares for $7.31 each. As a result, the insider received 32,237 and left with 19,879 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASPN now has a Market Capitalization of 244635360 and an Enterprise Value of 244068352. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.69 while its Price-to-Book (P/B) ratio in mrq is 0.80. Its current Enterprise Value per Revenue stands at 0.692 whereas that against EBITDA is 7.189.
Stock Price History:
The Beta on a monthly basis for ASPN is 2.94, which has changed by -0.75435686 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, ASPN has reached a high of $14.30, while it has fallen to a 52-week low of $2.87. The 50-Day Moving Average of the stock is -41.78%, while the 200-Day Moving Average is calculated to be -52.22%.
Shares Statistics:
The stock has traded on average 2.36M shares per day over the past 3-months and 1642150 shares per day over the last 10 days, according to various share statistics. A total of 82.56M shares are outstanding, with a floating share count of 69.05M. Insiders hold about 16.45% of the company’s shares, while institutions hold 72.03% stake in the company. Shares short for ASPN as of 1764288000 were 8561660 with a Short Ratio of 3.63, compared to 1761868800 on 8544699. Therefore, it implies a Short% of Shares Outstanding of 8561660 and a Short% of Float of 12.370000000000001.
Earnings Estimates
Currently, 5.0 analysts are dedicated to thoroughly evaluating and rating the performance of Aspen Aerogels Inc (ASPN) in the stock market.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.06 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.32 and -$3.99 for the fiscal current year, implying an average EPS of -$1.3. EPS for the following year is -$0.32, with 5.0 analysts recommending between -$0.18 and -$0.47.
Revenue Estimates
7 analysts predict $44.42M in revenue for. The current quarter. It ranges from a high estimate of $48.3M to a low estimate of $40.5M. As of. The current estimate, Aspen Aerogels Inc’s year-ago sales were $123.09MFor the next quarter, 7 analysts are estimating revenue of $49.1M. There is a high estimate of $56.7M for the next quarter, whereas the lowest estimate is $44M.
A total of 7 analysts have provided revenue estimates for ASPN’s current fiscal year. The highest revenue estimate was $278.1M, while the lowest revenue estimate was $270.3M, resulting in an average revenue estimate of $274.21M. In the same quarter a year ago, actual revenue was $452.7MBased on 7 analysts’ estimates, the company’s revenue will be $236.43M in the next fiscal year. The high estimate is $259.65M and the low estimate is $205.4M.
